| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amicus Therapeutics, Inc. (FOLD) has 6 insiders with recent SEC Form 4 filings, including 1 buy and 10 sells. FOLD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.02M | $14.80M | - | |
| Other | 464.6K | $6.73M | - | |
| Other | 409.3K | $5.93M | - | |
| Other | 221.8K | $3.21M | - | |
| CFO | 143.6K | $2.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2020 | Barth Jay | Chief Medical Officer | Sell | 1,904 | $13.47 | $25,639.45 | -1.2% | |
| Jun 16, 2020 | Prout Samantha68 | Principal Accounting Officer | Sell | 2,932 | $12.95 | $37,958.55 | -14.6% | |
| Jun 15, 2020 | Crowley John F67 | Chairman &CEO | Sale+OE | 20,000 | $10.88 | $217,610.00 | -2.2% | |
| Jun 2, 2020 | Whitman Burke W50 | Director | Buy | 2,000 | $12.66 | $25,310.80 | +9.3% | |
| Jun 2, 2020 | Campbell Bradley L66 | Chief Operating Officer | Sale+OE | 20,002 | $12.70 | $254,019.81 | -2.8% | |
| Jun 1, 2020 | Raab Michael56 | Director | Sale+OE | 5,000 | $12.65 | $63,260.50 | -24.8% | |
| Jun 1, 2020 | Crowley John F67 | Chairman &CEO | Sell | 9,755 | $12.66 | $123,452.45 | -1.1% | |
| May 26, 2020 | Campbell Bradley L66 | Chief Operating Officer | Sale+OE | 2,500 | $13.01 | $32,525.00 | -0.7% | |
| May 15, 2020 | Crowley John F67 | Chairman &CEO | Sale+OE | 20,000 | $11.44 | $228,796.00 | -2.1% | |
| May 1, 2020 | Campbell Bradley L66 | Chief Operating Officer | Sale+OE | 17,503 | $11.33 | $198,238.98 | -4.7% |